McCloskey EV, Johansson H, Harvey NC, Lorentzon M, et al. Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study. Osteoporos Int 2021 Feb 3. pii: 10.1007/s00198-020-05815.
PMID: 33537844